The policy continues to support all kinds of enterprises to go overseas to list! Medical stocks rebounded

Recently, affected by the rumors that the policy level may tighten the listing of private medical enterprises, on the day of 3.15, the stock prices of private medical companies listed on A-share and H-shares fell sharply. So, at the policy level, will the listing policy of private medical institutions usher in great changes? This can be seen in the spirit of the special meeting held by the Financial Stability and Development Committee of the State Council on March 16.

The author | Zhou Xin

Source| Medical Community (ID: vistamed)

The policy signal is coming, and the medical stocks have ushered in a big rebound

Affected by the rumors that the policy level may tighten the listing of private medical care, on the day of 3.15, the stock prices of private medical companies listed on A-share and H-share companies fell sharply. At the policy level, will the listing policy of private medical institutions usher in great changes? This can be seen in the spirit of the special meeting held by the Financial Stability and Development Committee of the State Council on March 16:

According to Xinhua News Agency, as a special meeting to study the current economic situation and capital market issues, presided over by Liu He, vice premier of the State Council and director of the Financial Commission, the meeting pointed out that under the current complex situation, the most crucial thing is to adhere to the principle that development is the most important task for the party to govern and rejuvenate the country, persist in taking economic construction as the central task, persist in deepening reform and opening wider to the outside world, adhere to the principles of marketization and the rule of law, adhere to the "two unwavering," earnestly protect property rights, and fully implement the spirit of the central economic work conference and the arrangements of the "two sessions" throughout the country. Coordinate epidemic prevention and control and economic and social development, keep economic operation within a reasonable range, and maintain the smooth operation of the capital market.

The meeting also stressed that relevant departments should earnestly assume their responsibilities, actively introduce policies favorable to the market, and prudently introduce contractionary policies. Respond to hot issues of market concern in a timely manner. Policies that have a significant impact on the capital market should be coordinated with the financial management authorities in advance to maintain the stability and consistency of policy expectations.

It also clearly emphasized that the government continues to support all kinds of enterprises to list overseas, and welcomes long-term institutional investors to increase their shareholding ratios.

As soon as the news came out, A shares and H shares rebounded, taking Hygia Medical as an example, on March 15, it fell 30%, closing at 20.2 yuan per share, and the market value fell to 12.48 billion Hong Kong dollars; and as of the close of March 16, Hygia Medical rose 48% from the previous day, with a share price of 29.95 yuan per share, and the market value returned to 18.5 billion Hong Kong dollars, which has recovered the lost ground on March 15.

In the A-share market, although the closing gains of medical stocks can not be compared with Hygia Medical, but also experienced a huge bottoming out in the intraday, taking the ophthalmology leader Aier Ophthalmology as an example, after a sharp decline of more than 10% on March 15, the intraday decline of more than 6% on March 16, the stock price bottomed out for two consecutive days at the 25 yuan mark, but with the news of the special meeting of the Financial Stability and Development Committee of the State Council, Aier Ophthalmology closed red, closing at 27.27 yuan per share, with a total market value of 147.425 billion yuan.

In addition, the leading dental stock Tongce Medical also experienced a sharp bottoming recovery, closing in red on March 16, closing at 122.88 yuan per share.

The wave of listings of healthcare providers continues

According to the "Medical Community", in recent years, with the continuous opening of social medical policies, the investment of medical service enterprises can be described as in full swing, more and more large-scale medical service enterprises, and the demand for rapid development with the help of the secondary market is also becoming more and more vigorous, and a number of medical companies have impacted the listing.

Mainland medical service enterprises, including Chaoju Ophthalmology, Gushengtang, Hygia Medical, Hongli Medical and other mainland medical service enterprises, have successfully landed in the Hong Kong stock market.

It is understood that since 2013, the Hong Kong stock market as a place for the listing of medical service enterprises has become more and more mature, and the main board of Hong Kong has gradually formed a plate effect of medical service enterprises.

The medical service institutions listed in Hong Kong include not only local specialized for-profit medical institutions in Hong Kong, China, but also general hospitals and specialist hospitals from Chinese mainland, some of which are specialized hospitals with individual patient payments and commercial insurance payments as the main income, such as New Century Medical, and there are also general hospitals and specialized hospitals with the payment of basic medical insurance Chinese mainland the government as the main medical income, such as Honghe Ren'ai, Kanghua Hospital and Corning Hospital.

Hong Haomiao, head of Medical Science Capital, said that compared with hong Kong local medical service enterprises, which account for the majority of hong Kong stock listings, Chinese mainland medical service companies are the main force in the Hong Kong stock market, whether from the perspective of financing scale, market value or price-earnings ratio.

It can be seen that the enthusiasm of mainland medical service enterprises to go public in Hong Kong is high.

Therefore, the spirit of the meeting that "the government continues to support all kinds of enterprises to go overseas" can be said to have played a key role in the recovery of confidence in the medical investment market, and the sharp rebound in medical stocks is the best response.

In addition, in the A-share market, 2021 will also usher in a number of major benefits for the listing of medical service companies, including Sanbo Brain, Huaxia Ophthalmology, Puri Ophthalmology, etc. medical companies will be listed in A-shares, giving the medical and health industry greater investment confidence.

It is foreseeable that in 2022, some medical companies will be officially listed on A-shares, and many medical companies will continue to list in Hong Kong.

Industry insiders said that the high-quality development of social medical services, can not be separated from the capital market, especially the support of the secondary market, the smooth flow of financing channels, standardized enterprise management will plug wings for the healthy development of social medical services; of course, the listing of enterprises also means stricter supervision, listing is not the purpose and end of the development of medical enterprises, but a new starting point; some listed medical enterprises that forget the original intention and violate laws and regulations are easy to thunder, and even forced to withdraw from the market. (This article is published by "Seeing the Medical Community", reprinted with permission, and the author and source are indicated at the beginning of the article.) ）

END

The 2022 National Hospital Operation Conference is coming!

From "large-scale construction" to "fine operation", how to establish a modern hospital management system? How to achieve refined, high-quality and leapfrog development of medical institutions through benign operation? How to build a market-recognized brand ?.... On May 28-29, the 2022 National Hospital Operation Conference sponsored by the 2022 Shanghai Medical Fair Expert Committee, the Institute of Social Medical Institutions of Shanghai Jiaotong University, and the medical media will be held in Shanghai.